Gillian Gresham

1.7k total citations
70 papers, 902 citations indexed

About

Gillian Gresham is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Gillian Gresham has authored 70 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Physiology. Recurrent topics in Gillian Gresham's work include Colorectal Cancer Treatments and Studies (14 papers), Cancer survivorship and care (14 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Gillian Gresham is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Cancer survivorship and care (14 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Gillian Gresham collaborates with scholars based in United States, Canada and Israel. Gillian Gresham's co-authors include Curtis L. Meinert, Andrew Hendifar, Steven Piantadosi, A. Shinde, Robert A. Figlin, Richard Tuli, Jennifer A. Schrack, Derek J. Jonker, B.J. Rimel and Jill Meinert and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Gillian Gresham

65 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Gresham United States 16 469 195 182 153 129 70 902
Lisa Vandermeer Canada 18 572 1.2× 148 0.8× 234 1.3× 287 1.9× 151 1.2× 108 1.1k
Inge R. Konings Netherlands 17 453 1.0× 119 0.6× 220 1.2× 89 0.6× 228 1.8× 42 1.0k
Michael J. Messino United States 14 475 1.0× 309 1.6× 215 1.2× 82 0.5× 147 1.1× 33 950
Janise M. Roh United States 19 720 1.5× 176 0.9× 145 0.8× 87 0.6× 146 1.1× 80 1.2k
John Coombs United States 17 289 0.6× 85 0.4× 150 0.8× 102 0.7× 140 1.1× 45 1.4k
Pauline A. J. Vissers Netherlands 23 722 1.5× 125 0.6× 306 1.7× 284 1.9× 160 1.2× 88 1.4k
Susan Moore United States 14 247 0.5× 154 0.8× 117 0.6× 132 0.9× 66 0.5× 37 814
Mark S. Clanton United States 8 338 0.7× 145 0.7× 180 1.0× 83 0.5× 78 0.6× 13 895
Kumiko Saika Japan 13 325 0.7× 129 0.7× 181 1.0× 146 1.0× 87 0.7× 80 889
Trevor A. Jolly United States 14 460 1.0× 314 1.6× 252 1.4× 69 0.5× 95 0.7× 32 953

Countries citing papers authored by Gillian Gresham

Since Specialization
Citations

This map shows the geographic impact of Gillian Gresham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Gresham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Gresham more than expected).

Fields of papers citing papers by Gillian Gresham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Gresham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Gresham. The network helps show where Gillian Gresham may publish in the future.

Co-authorship network of co-authors of Gillian Gresham

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Gresham. A scholar is included among the top collaborators of Gillian Gresham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Gresham. Gillian Gresham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gresham, Gillian, Michael Luu, N. Lynn Henry, et al.. (2025). Clinician and Patient Perspectives on a Patient-Facing Online Breast Cancer Symptom Visualization Tool. JCO Clinical Cancer Informatics. 9(9). e2400109–e2400109. 1 indexed citations
2.
Gresham, Gillian, et al.. (2025). Predicting Engagement Patterns With Connected Wearable Devices in a Health System: Survival Analysis. Journal of Medical Internet Research. 27. e78507–e78507.
3.
Gresham, Gillian, N. Lynn Henry, Hanna Bandos, et al.. (2025). Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials. Cancer. 131(S2). e70086–e70086.
4.
5.
Posadas, Edwin M., et al.. (2024). Applications of wearable activity monitors for prostate cancer survivors: A systematic scoping review. Contemporary Clinical Trials. 143. 107563–107563. 3 indexed citations
6.
Luu, Michael, Gillian Gresham, N. Lynn Henry, et al.. (2024). Development of a Web-Based Interactive Tool for Visualizing Breast Cancer Clinical Trial Tolerability Data. JCO Clinical Cancer Informatics. 8(8). e2400007–e2400007. 3 indexed citations
7.
Calsavara, Vinícius F., N. Lynn Henry, Ron D. Hays, et al.. (2023). Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial. Cancer Prevention Research. 16(11). 631–639. 3 indexed citations
8.
Shirazipour, Celina H., Márcio A. Diniz, Gillian Gresham, et al.. (2023). Benefits of nature-based walking for breast cancer survivors. BMJ Open. 13(6). e071041–e071041. 2 indexed citations
9.
Shirazipour, Celina H., Márcio A. Diniz, Sarah‐Jeanne Salvy, et al.. (2023). The 24-Hour Movement Paradigm: An integrated approach to the measurement and promotion of daily activity in cancer clinical trials. Contemporary Clinical Trials Communications. 32. 101081–101081. 5 indexed citations
10.
Henry, N. Lynn, Sungjin Kim, Ron D. Hays, et al.. (2022). Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. npj Breast Cancer. 8(1). 123–123. 6 indexed citations
11.
Hays, Ron D., Gillian Gresham, Patricia A. Ganz, & Mourad Tighiouart. (2022). Comparison of Simple-Summated Scoring and Toxicity Index Scoring of Symptom Bother in the NSABP B-30 Clinical Trial. Applied Research in Quality of Life. 18(2). 697–707. 1 indexed citations
12.
Idossa, Damé, Hala T. Borno, Mark J. Pletcher, et al.. (2022). Ethnic and Racial Inequities in Cancer Screening During the COVID-19 Pandemic: a multi-site observational study in the United States. 2(2). 3 indexed citations
13.
Gong, Jun, Sungjin Kim, Gillian Gresham, et al.. (2022). Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma. Scientific Reports. 12(1). 15013–15013. 9 indexed citations
14.
Gresham, Gillian, Márcio A. Diniz, Michael Luu, et al.. (2020). Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index. JNCI Journal of the National Cancer Institute. 112(12). 1266–1274. 28 indexed citations
15.
Gresham, Gillian, Andrew Hendifar, Brennan Spiegel, et al.. (2018). Wearable activity monitors to assess performance status and predict clinical outcomes in advanced cancer patients. npj Digital Medicine. 1(1). 27–27. 117 indexed citations
16.
David, John, Gillian Gresham, Salma K. Jabbour, et al.. (2018). Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer. Journal of Gastrointestinal Oncology. 9(4). 641–649. 3 indexed citations
17.
Gresham, Gillian, Jennifer A. Schrack, A. Shinde, et al.. (2017). Wearable activity monitors in oncology trials: Current use of an emerging technology. Contemporary Clinical Trials. 64. 13–21. 100 indexed citations
18.
Chan, Matthew, et al.. (2016). Population-Based Patterns and Factors Associated With Underuse of Palliative Systemic Therapy in Elderly Patients With Metastatic Colon Cancer. Clinical Colorectal Cancer. 16(2). 147–153. 15 indexed citations
19.
20.
Gresham, Gillian, et al.. (2014). Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis. BMC Cancer. 14(1). 471–471. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Vandermeer Breakdown of academic impact, for papers by Inge R. Konings Breakdown of academic impact, for papers by Michael J. Messino Breakdown of academic impact, for papers by Janise M. Roh Breakdown of academic impact, for papers by John Coombs Breakdown of academic impact, for papers by Pauline A. J. Vissers Breakdown of academic impact, for papers by Susan Moore Breakdown of academic impact, for papers by Mark S. Clanton Breakdown of academic impact, for papers by Kumiko Saika Breakdown of academic impact, for papers by Trevor A. Jolly
Rankless by CCL
2026